Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

328 LICORICE
Reactions
Skin
Dermatitis
(1999): Nishioka K+, Contact Dermatitis 40(1), 56
Edema
(2000): Negro A+, Ann Ital Med Int 15(4), 296
(2000): Olukoga A+, JRSocHealth120(2), 83
Eyes
Ocular adverse effects
(2004): Fraunfelder FW, Am J Ophthalmol 138(4), 639
Other
Myalgia/Myositis/Myopathy/Myotoxicity
Rhabdomyolysis
(2005): van den Bosch AE+, Neth J Med 63(4), 146
(2003): Hussain RM, Postgrad Med J 79(928), 115
(2002): Firenzuoli F+, Recenti Prog Med 93(9), 482
(2002): Sardi A+, Ann Ital Med Int 17(2), 126
(1997): Barrella M+, Ital J Neurol Sci 18(4), 217
(1995): Berlango Jimenez A+, An Med Interna 12(1), 33
(1992): Caradonna P+, Ultrastruct Pathol 16(5), 529
(1989): Achar KN+, Aust N Z J Med 19(4), 365
(1988): Maresca MC+, Minerva Med 79(1), 55 (3 cases)
(1985): Ruggeri CS+, Minerva Med 76(14–15), 725
(1983): Corsi FM+, Ital J Neurol Sci 4(4), 493
(1983): Heidemann HT+, Klin Wochenschr 61(6), 303
(1982): Yokoyama F+, Rinsho Shinkeigaku 22(6), 552
(1980): Cumming AM+, Postgrad Med J 56(657), 526
LIDOCAINE
Synonym: lignocaine
Trade names: Anamantle HC (Doak); Anestacon; Dentipatch;
DermaFlex; Dilocaine; ELA-Max (Ferndale); EMLA
(AstraZeneca); Lidodan; Lidoderm (Endo); Lidoject-2; Octocaine;
Xylocaine (AstraZeneca); Xylocard
Indications: Ventricular arrhythmias, topical anesthesia
Category: Anesthetic, local; Antiarrhythmic class 1b
Half-life: terminal: 1.5–2 hours
Clinically important, potentially hazardous interactions
with: amprenavir, antiarrhythmics, cimetidine, fosamprenavir,
nilutamide
Reactions
Skin
Allergic reactions (sic)
(2002): Helfman M, NYStateDentJ68(10), 24
Angioedema
(1987): Bricker SR+, Anaesthesia 42, 323
Bullous dermatitis
Dermatitis
(2006): Jovanovic M+, Contact Dermatitis 54(2), 124
(2005): Ismail F+, Contact Dermatitis 52(2), 111
(2003): Gammaitoni AR+, J Clin Pharmacol 43(2), 111
(2002): Kaufmann JM+, J Drugs Dermatol 1(2), 192
(2001): Breit S+, Contact Dermatitis 45(5), 296
(1999): Lodi A+, Contact Dermatitis 41(4), 221
(1998): Downs AM+, Contact Dermatitis 39, 33
(1997): Kawada A+, Contact Dermatitis 37(1), 45
(1996): Bassett IB+, Australas J Dermatol 37, 155
(1996): Bircher AJ+, Contact Dermatitis 34, 387
(1996): Whalen JD+, Arch Dermatol 132, 1256
(1995): Thakur BK+, J Allergy Clin Immunol 95, 776
(1994): Hardwick N+, Contact Dermatitis 30, 245
(1993): Duggan M+, Contact Dermatitis 28, 190
(1993): Handfield-Jones SE+, Clin Exp Dermatol 18, 342
(1990): Black RJ+, Contact Dermatitis 23, 117
(1989): Budde J+, Derm Beruf Umwelt (German) 37, 181
(1986): Curley KR, Arch Dermatol 122, 924
(1985): Fernandes-de-Corres L+, Contact Dermatitis 12, 114
(1983): Nurse DS+, Contact Dermatitis 9, 513
(1983): van Ketel WG+, Contact Dermatitis 9(6), 512
(1980): Chin TM+, Int J Dermatol 19, 147
Eczema
(1990): Huwyler T+, Schweiz Monatsschr Zahnmed (German)
100, 751
(1986): Curley KR, Arch Dermatol 122, 924
Edema (